GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Reading the transcript was fairly encouraging. I believe the company can be profitable by mid-2008.<

No doubt that it can, but it will be a lumpy kind of profitability that depends on the timing of milestone payments from partners and how these payments are treated under GAAP.

Sustained profitability—the kind that can be counted on quarter after quarter—probably has to wait for U.S. Atryn sales.